Topics

Virpax Pharmaceuticals Company Profile

15:19 EDT 19th September 2019 | BioPortfolio

Virpax develops branded pharmaceutical products for pain management by using cutting-edge technology to enhance patients’ quality of life, all while creating value for its investors and partners. The company is focused on becoming a global leader in pain management by developing and delivering innovative pharmaceutical products to its customers. For more information, please visit www.virpaxpharma.com.


News Articles [835 Associated News Articles listed on BioPortfolio]

Virpax Pharmaceuticals to file IND later this year for pain management therapy

Virpax Pharmaceuticals Inc Chairman & CEO Anthony Mack spoke with Proactive Investors at the ThinkEquity Conference in New York. The privately-held, Pennsylvania-based company develops branded...

Virpax(R) Pharmaceuticals to Present at ThinkEquity Conference

MALVERN, PA / ACCESSWIRE / April 24, 2019 / Virpax® Pharmaceuticals Inc. ("Virpax"), a company specializing in developing pharmaceutical products for pain management by using new drug delivery system...

Gerald Bruce Joins Virpax(R) Pharmaceuticals as Executive Vice President, Commercial Operations

MALVERN, PA / ACCESSWIRE / September 17, 2019 / Virpax® Pharmaceuticals Inc. (“Virpax”) a company specializing in developing pharmaceutical products for pain management, today announced that Gera...

Virpax(R) Pharmaceuticals Announces Appointment of Michèle C. Linde, EVP, General Counsel

MALVERN, PA / ACCESSWIRE / June 11, 2019 / Virpax® Pharmaceuticals, Inc. ("Virpax"), a company specializing in developing pharmaceutical products for pain management, today announced the appointment ...

Virpax(R) Pharmaceuticals Announces the Appointment of Three Independent Directors

MALVERN, PA / ACCESSWIRE / September 10, 2019 / Virpax® Pharmaceuticals Inc. (“Virpax”) a company specializing in developing pharmaceutical products for pain management, is pleased to announce t...

FDA review gives Virpax go-ahead for pain relief candidates

A pre-IND review by the US FDA has allowed Virpax to continue with NDAs for DSF100 and LBL100, two pain relief products with specialised drug delivery formulations.

Virpax(R) Pharmaceuticals Selected for Two Presentations at the 2019 Military Health System Research Symposium

MALVERN, PA / ACCESSWIRE / June 3, 2019 / Virpax® Pharmaceuticals, Inc. ("Virpax"), a company specializing in developing pharmaceutical products for pain management, today announced that their Chief ...

Virpax(R) Pharmaceuticals to Present at the 2019 Military Health System Research Symposium

MALVERN, PA / ACCESSWIRE / August 6, 2019 / Virpax® Pharmaceuticals, Inc. (“Virpax”), a company specializing in developing pharmaceutical products for pain management, today announced that their ...

Drugs and Medications [0 Results]

None

PubMed Articles [138 Associated PubMed Articles listed on BioPortfolio]

Mytilidae as model organisms in the marine ecotoxicology of pharmaceuticals - A review.

Growing production and consumption of pharmaceuticals is a global problem. Due to insufficient data on the concentration and distribution of pharmaceuticals in the marine environment, there are no app...

Occurrence and ranking of pharmaceuticals in the major rivers of China.

Residual pharmaceuticals have received widespread attention worldwide due to their continuous release and potential hazard to the environment. As a result of rapid development and a large population, ...

Occurrence and distribution of pharmaceuticals in raw, finished, and drinking water from seven large river basins in China.

The occurrence of pharmaceuticals in the drinking water is a growing concern in China. In this study, we determined the concentration and distribution of 59 selected pharmaceuticals in raw, finished, ...

U.S. Emergency Department Visits Resulting From Nonmedical Use of Pharmaceuticals, 2016.

National data on morbidity from nonmedical use of pharmaceuticals are limited. This study used nationally representative, public health surveillance data to characterize U.S. emergency department visi...

Simultaneous aqueous chlorination of amine-containing pharmaceuticals.

Amine-containing pharmaceuticals such as acetaminophen, diclofenac, and sulfamethoxazole are the most often detected pharmaceuticals in wastewater and other aquatic environments. Amine-containing phar...

Clinical Trials [244 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [1382 Associated Companies listed on BioPortfolio]

Virpax Pharmaceuticals

Virpax develops branded pharmaceutical products for pain management by using cutting-edge technology to enhance patients’ quality of life, all while creating value for its in...

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

Excaliard Pharmaceuticals, Inc.

Excaliard Pharmaceuticals, Inc., is a venture capital-funded biotechnology company founded in 2007 focused on the development and commercialization of novel and innovative drugs for the amelioration o...

Serenity Pharmaceuticals

Founded in 2007 and located in Milford, Pennsylvania, Serenity Pharmaceuticals is focused on developing products that address urinary conditions that impact the health and well-be...

Avanir Pharmaceuticals

AVANIR Pharmaceuticals, formerly LIDAK Pharmaceuticals, is a development stage company organized to discover, develop, and market novel therapeutic products to treat human diseases.

More Information about "Virpax Pharmaceuticals" on BioPortfolio

We have published hundreds of Virpax Pharmaceuticals news stories on BioPortfolio along with dozens of Virpax Pharmaceuticals Clinical Trials and PubMed Articles about Virpax Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Virpax Pharmaceuticals Companies in our database. You can also find out about relevant Virpax Pharmaceuticals Drugs and Medications on this site too.

Quick Search

Relevant Topic

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...


Corporate Database Quicklinks



Searches Linking to this Company Record